The immune‐metabolism interactome in efferocytosis: a new paradigm for the central nervous system diseases revealed by single‐cell sequencing analysis
The Journal of Pathology · 2026
DOI: 10.1002/path.70031 ↗At a glance
Übersichtsarbeit in The Journal of Pathology, 2026. Written by Huiyi Zhang and 5 co-authors. Institution: Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, PR China. Major MEDLINE topics: Efferocytosis, Central Nervous System Diseases, Microglia, Single-Cell Analysis. Cited 1 times so far (Crossref); 201 references. Funded by: 345 Talent Project of Shengjing Hospital of China Medical University, National Natural Science Foundation of China.
Abstract (original language)
Efferocytosis is a process that maintains tissue homeostasis by removing apoptotic cells (ACs) by professional or non‐professional phagocytes. The intricate process can be categorized into recognition of ACs, engulfment of ACs, and degradation of efferosomes. Aberrations in efferocytosis result in inadequate clearance of ACs, leading to prolonged inflammation that is implicated in the development and progression of various human diseases. Most central nervous system (CNS) diseases are associated with dysregulation of inflammatory homeostasis. Microglia, the resident immune cells of the CNS, play a primary role in efferocytosis in the brain, which is essential for maintaining the homeostasis of the internal environment. In this review, we summarize the current knowledge of the basic processes of efferocytosis and its indispensable role in the developing and aging brain. Additionally, we discuss the regulatory role of immune‐metabolism crosstalk and the insights from single‐cell sequencing analysis in dissecting microglial heterogeneity during efferocytosis. We also focus on recent discoveries regarding the critical role of efferocytosis in several CNS diseases, including cerebral ischemia, intracerebral hemorrhage, traumatic brain injury, major depressive disorder, glioblastoma multiforme, Alzheimer's disease, and Parkinson's disease. Finally, we outline potential therapeutic strategies and existing challenges, emphasizing the need for context‐specific targeting to improve CNS disease outcomes. © 2026 The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, PR China.
- Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, PR China.
ORCID profiles: Ying Xu
Funding
- 345 Talent Project of Shengjing Hospital of China Medical University
- National Natural Science Foundation of China
Cite
APA
Zhang, H., Li, W., Xiao, P., Lu, Z., Tian, Y., & Xu, Y. (2026). The immune‐metabolism interactome in efferocytosis: a new paradigm for the central nervous system diseases revealed by single‐cell sequencing analysis. The Journal of Pathology. https://doi.org/10.1002/path.70031
Vancouver
Zhang H, Li W, Xiao P, Lu Z, Tian Y, Xu Y. The immune‐metabolism interactome in efferocytosis: a new paradigm for the central nervous system diseases revealed by single‐cell sequencing analysis. The Journal of Pathology. 2026. doi:10.1002/path.70031
BibTeX
@article{Zhang2026,
author = {Zhang, Huiyi and Li, Wenbin and Xiao, Peilun and Lu, Zeyao and Tian, Ye and Xu, Ying},
title = {The immune‐metabolism interactome in efferocytosis: a new paradigm for the central nervous system diseases revealed by single‐cell sequencing analysis},
journal = {The Journal of Pathology},
year = {2026},
doi = {10.1002/path.70031}
}
EUVIMED